Skip To Main Content
Yuanying Yang on Muck Rack

Yuanying Yang

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yuanying

Contact Yuanying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Low-dose turbidity control using cationic polysaccharide bioflocculants: performance, dosage tolerance and molecular interpretation

|
By Yuanying Yang, Wenshan Guo, Huiying Zhang, Soon Woong Chang, Dinh Nguyen, Dongle Cheng, Yuanyao Ye, Xuan Bui, Xuân Bùi, Huu Hao Ngo
| Nature Verified
Abstract Bioflocculants are being developed as sustainable alternatives to inorganic coagulants for turbidity control, but how polysaccharide backbones affect the performance of cationically modified bioflocculants remains insufficiently understood. Here, modified starch (M-Starch) and modified chitosan (M-Chitosan) carrying quaternary ammonium groups were compared in kaolin suspensions under high- and low-turbidity conditions.
Open in Who Shared Issue with article?

Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases

|
By Pengcheng Sun, Yuanying Yang, Xiuyi Ou
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. References , , , , , and . 2022. “Dapagliflozin Exerts Anti-Inflammatory Effects via Inhibition of LPS-Induced TLR-4 Overexpression and NF-κB Activation in Human Endothelial Cells and Differentiated Macrophages.” European Journal of Pharmacology 918: 174715.
Open in Who Shared Issue with article?

Mitigating Doxorubicin‐Induced Cardiotoxicity and Enhancing Anti‐Tumor Efficacy with a Metformin‐Integrated Self‐Assembled Nanomedicine

|
By Jiaxin Huang, Jieru Yang, Yuanying Yang, Xiaofeng Lu
| Wiley Online Library Verified
1 Introduction Malignant tumors are a significant global health burden and one of the most formidable challenges in modern medicine.[1] Chemotherapy remains a cornerstone of cancer treatment, employing cytotoxic drugs to eradicate tumor cells, and is recommended as a first-line therapy in clinical guidelines worldwide.[2] Doxorubicin (Dox), an anthracycline chemotherapeutic agent, is widely used due to its broad anti-tumor spectrum and potent cytotoxic effects, effectively treating breast,...
Open in Who Shared Issue with article?
See all 5 articles